Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.5 SEK | +2.63% | +1.56% | +26.13% |
May. 08 | Transcript : Orexo AB, Q1 2024 Earnings Call, May 08, 2024 | |
Apr. 17 | Orexo Expands, Extends US Patent for Nasal Anaphylaxis Treatment | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.13% | 60.36M | |
+9.85% | 72.5B | |
+13.69% | 9.11B | |
-12.85% | 5.07B | |
+60.16% | 5.01B | |
+1.60% | 3.85B | |
-19.20% | 2.46B | |
+18.65% | 2.44B | |
+24.62% | 2.27B | |
-27.46% | 2.26B |
- Stock Market
- Equities
- ORX Stock
- News Orexo AB
- Transcript : Orexo AB, Q2 2021 Earnings Call, Jul 15, 2021